Physician profile
Patrick Hanson
NPI 1558698423
$1,841.50
in general payments reported to CMS, 2019-2025
11 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $23.83 · 2021: $56.99 · 2022: $108 · 2023: $15.20 · 2024: $44.03 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $937 · Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $936.82 |
| Food and Beverage | $103.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $525.44 | 2024-2025 | |
| Arthrex, INC. | $482.45 | 2025 | |
| Omnilife Science, INC | $408.77 | 2019 | |
| Medacta USA, INC. | $179.79 | 2019-2024 | Mpact |
| Sanara Medtech INC. | $95.92 | 2022 | |
| Amgen INC. | $83.15 | 2019-2021 | |
| Abbott Laboratories | $15.32 | 2021 | |
| Globus Medical, INC. | $14.48 | 2019 | |
| Ermi LLC | $12.90 | 2021 | |
| Vericel Corporation | $12.34 | 2019 | |
| Dynasplint Systems INC. | $10.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.